# GE HealthCare Technologies Inc. Common Stock (GEHC) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Technology / Software. Price $68.86, market value $31.1 billion.

## Valuation
- **P/E (trailing): 15.9×** (5-yr avg 18.8×, 3-yr avg 20.5×). GE HealthCare Technologies Inc. Common Stock trades at 15.9× trailing earnings, close to its own five-year average of 18.8×. The Technology median in the September 2026 study was 32.1×. Forward P/E is 12.7×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 2.63**. A PEG of 2.63 means the P/E is high relative to expected earnings growth; the price already assumes a lot.
- **Price / sales: 1.5×**. Each dollar of revenue is priced at 1.5×.
- **Price / book: 2.8×**. The shares trade at 2.8× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 5.1%** (5-yr avg 5.0%). Free cash flow equals 5.1% of the market value, in line with its five-year average of 5.0%. Above 5% is generally attractive.
- **Earnings yield: 6.3%**. The inverse of the P/E: 6.3% of the price is earned each year.

## Profitability
- **Gross margin: 39.5%**. GE HealthCare Technologies Inc. Common Stock keeps 39.5% of revenue after the direct cost of what it sells.
- **Operating margin: 12.9%**. 12.9% of revenue is left after running the business.
- **Net margin: 10.1%**. 10.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 20.1%**. 20.1% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 13.6%**. Return on all capital, debt included, is 13.6%.
- **Return on assets: 5.4%**. Each dollar of assets produces 5.4% of profit.

## Growth
- **Revenue growth (1 yr): 4.8%** (3-yr 4.0%/yr). Revenue grew 4.8% over the last year.
- **EPS growth (1 yr): 4.8%** (3-yr 2.5%/yr). Earnings per share rose 4.8%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): -6.2%/yr**. Free cash flow has compounded at -6.2% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.96**. Debt is 0.96 times equity, moderate leverage.
- **Altman Z-score: 1.91**. A Z-score of 1.91 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 0.20%** ($0.14 per share, trailing). GE HealthCare Technologies Inc. Common Stock yields 0.20%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 3%** (4% of free cash flow). 3% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 3**. 3 straight years of increases.

## Analyst view
- **Analyst consensus: buy** (18 analysts). 18 analysts cover GE HealthCare Technologies Inc. Common Stock; the consensus is buy, with an average price target of $82.50 (+20% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -6.9%** (YTD -15.9%, 3-mo 6.5%). The shares are down 6.9% over twelve months including dividends.
- **From 52-week high: -23.3%** (17.2% above the low). Trading 23% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 42**. An RSI of 42 is neutral.
- **Beta (1 yr): 0.81** (volatility 35%). Beta of 0.81 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=GEHC · Page: https://foliofundamentals.com/stocks/gehc

Not investment advice.